Back to Search
LOGAN WAGNER, PHARMD
PHARMD
Pharmacist
NPI: 1235731019Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
03233013(OH)
Research & Publications (20)
New therapeutic targets for the treatment of high-risk neuroblastoma.
PMID 19277986·J Cell Biochem·2009
6-review
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
PMID 19171709·J Clin Oncol·2009
3-trial
Children's understanding of directed motion events in an imitation choice task.
PMID 18490027·J Exp Child Psychol·2008
2-rct
Targeting methylguanine-DNA methyltransferase in the treatment of neuroblastoma.
PMID 17875772·Clin Cancer Res·2007
7-preclinical
Cognitive adaptability as a moderator of expressive writing effects in an HIV sample.
PMID 18607714·AIDS Behav·2010
2-rct
Risedronate reduces intracortical porosity in women with osteoporosis.
PMID 19580469·J Bone Miner Res·2010
2-rct
Nurses' perceptions of safety culture in long-term care settings.
PMID 19538703·J Nurs Scholarsh·2009
8-other
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
PMID 19560002·J Vasc Interv Radiol·2009
8-other
Updated prevalence estimates of multiple sclerosis in Texas, 1998 to 2003.
PMID 19492265·Tex Med·2009
4-observational
Quality improvement guidelines for recording patient radiation dose in the medical record.
PMID 19560000·J Vasc Interv Radiol·2009
8-other
ATP regulation of type-1 inositol 1,4,5-trisphosphate receptor activity does not require walker A-type ATP-binding motifs.
PMID 19386591·J Biol Chem·2009
7-preclinical
A kinetic model of the inositol trisphosphate receptor based on single-channel data.
PMID 19450477·Biophys J·2009
7-preclinical
Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
PMID 19501205·Vaccine·2009
4-observational
Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody.
PMID 19342084·J Allergy Clin Immunol·2009
5-case
TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage.
PMID 19564573·J Leukoc Biol·2009
7-preclinical
Protein kinase A increases type-2 inositol 1,4,5-trisphosphate receptor activity by phosphorylation of serine 937.
PMID 19608738·J Biol Chem·2009
7-preclinical
Evaluating the dimensionality of perceived cognitive function.
PMID 19500722·J Pain Symptom Manage·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1795 COLUMBUS AVE
WASHINGTON COURT HOUSE, OH 43160 - Phone
- (740) 335-6162
Quick Facts
- NPI
- 1235731019
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile